Our team will discuss the number of treatment sessions required once a personalized treatment plan is created
04, 2025 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
However, this study is available only as an abstract, and its reliability is largely unknown
Minor injection site discomfort is possible but minimized with proper technique
But a growing number of Americans are now taking peptides that, unlike those drugs, haven't undergone a rigorous testing and approval process
Therapeutic category: Hypoglycemic drug - analog of glucagon-like peptide-1 (GLP-1)